Point-of-care bulk testing for SARS-CoV-2 by combining hybridization capture with improved colorimetric LAMP
- PMID: 33674580
- PMCID: PMC7935920
- DOI: 10.1038/s41467-021-21627-0
Point-of-care bulk testing for SARS-CoV-2 by combining hybridization capture with improved colorimetric LAMP
Abstract
Efforts to contain the spread of SARS-CoV-2 have spurred the need for reliable, rapid, and cost-effective diagnostic methods which can be applied to large numbers of people. However, current standard protocols for the detection of viral nucleic acids while sensitive, require a high level of automation and sophisticated laboratory equipment to achieve throughputs that allow whole communities to be tested on a regular basis. Here we present Cap-iLAMP (capture and improved loop-mediated isothermal amplification) which combines a hybridization capture-based RNA extraction of gargle lavage samples with an improved colorimetric RT-LAMP assay and smartphone-based color scoring. Cap-iLAMP is compatible with point-of-care testing and enables the detection of SARS-CoV-2 positive samples in less than one hour. In contrast to direct addition of the sample to improved LAMP (iLAMP), Cap-iLAMP prevents false positives and allows single positive samples to be detected in pools of 25 negative samples, reducing the reagent cost per test to ~1 Euro per individual.
Conflict of interest statement
The authors declare no competing interests.
Figures



References
Publication types
MeSH terms
Substances
Supplementary concepts
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous